Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A
DNA
Market Cap$0
Close$
$-7.93
198% downside
Current Fair Value
198% downsideOvervalued by 198% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $155.79 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-18.37 |
| Beta | 1.1 |
| Outstanding Shares | 51,370,025 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.48 |
|---|---|
| PEG | 0.59 |
| Price to Sales | 2.02 |
| Price to Book Ratio | 0.67 |
| Enterprise Value to Revenue | 0.71 |
| Enterprise Value to EBIT | -0.3 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 3.01 |
| Debt to Equity | 0.72 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ginkgo Bioworks Holdings Inc
2,021 employeesSoaring Eagle Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses....